In high-fat-, high-cholesterol-diet-fed apolipoprotein E knockout mice, liver-directed hFGF1<sup>ΔHBS</sup> expression markedly reduced hepatic steatosis, inflammation, and fibrosis, independent of changes in body weight, blood glucose, insulin sensitivity, body composition, or circulating triglyceride and cholesterol levels. This evidence concerns the gene APOE and fatty liver disease.